KLK3 and sarcopenia: In summary, sarcopenia determined by cross-sectional areas of skeletal muscles on baseline CT is an independent prognostic factor for predicting poor FFS and time to PSA progression in patients with mHSPC receiving treatment with early docetaxel or abiraterone acetate.